REDUCTION OF 2,4-DINITROTOLUENE BY WISTAR RAT-LIVER MICROSOMAL AND CYTOSOL FRACTIONS

被引：17

作者：

MORI, MA

MATSUHASHI, T

MIYAHARA, T

SHIBATA, S

IZIMA, C

KOZUKA, H

机构：

来源：

关键词：

D O I：

10.1016/0041-008X(84)90033-4

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：105 / 112

页数：8

共 31 条

[1] MUTAGENICITY AND IRREVERSIBLE BINDING OF THE HEPATOCARCINOGEN, 2,4-DIAMINOTOLUENE
AUNE, T
NELSON, SD
DYBING, E
[J]. CHEMICO-BIOLOGICAL INTERACTIONS, 1979, 25 (01) : 23 - 33
[2] BOND JA, 1981, J PHARMACOL EXP THER, V219, P598
[3] BOND JA, 1981, DRUG METAB DISPOS, V9, P10
[4] CARDY RH, 1979, J NATL CANCER I, V62, P1107
[5] HEPATIC-MICROSOMAL METABOLISM AND COVALENT BINDING OF 2,4-DINITROTOLUENE
DECAD, GM
GRAICHEN, ME
DENT, JG
[J]. TOXICOLOGY AND APPLIED PHARMACOLOGY, 1982, 62 (02) : 325 - 334
[6] DERENZO EC, 1956, ADV ENZYMOL REL S BI, V17, P293
[7] POTENTIATION BY INHIBITION OF DRUG DEGRADATION - 6-SUBSTITUTED PURINES AND XANTHINE OXIDASE
ELION, GB
RUNDLES, RW
NATHAN, H
CALLAHAN, S
HITCHINGS, GH
BIEBER, S
[J]. BIOCHEMICAL PHARMACOLOGY, 1963, 12 (01) : 85 - &
[8] ELLIS HV, 1979, 7 MIDW RES I FIN REP
[9] ENZYMATIC REDUCTION OF NIRIDAZOLE BY RAT LIVER MICROSOMES
FELLER, DR
MORITA, M
GILLETTE, JR
[J]. BIOCHEMICAL PHARMACOLOGY, 1971, 20 (01) : 203 - &
[10] GILLETTE JR, 1968, MOL PHARMACOL, V4, P541